Company Filing History:
Years Active: 2021-2023
Title: The Innovative Mind of Pernille F. Jensen
Introduction
Pernille F. Jensen is a notable inventor based in Taastrup, Denmark, recognized for her contributions to biotechnology. With a portfolio of five patents, she has made significant advancements in the field, particularly in enzyme variants and their applications.
Latest Patents
One of her latest inventions revolves around "GH9 endoglucanase variants and polynucleotides encoding same." This invention describes novel endoglucanase variants and outlines methods for their production. It also includes polynucleotides that encode these variants, as well as nucleic acid constructs, vectors, and host cells comprising them, highlighting their utility in various applications.
Another recent patent is focused on "Xanthan lyase variants and polynucleotides encoding same." Similar to her previous work, this invention details xanthan lyase variants along with methods for generating them. The invention further includes polynucleotides that encode these variants and various applications of these innovative variants in biotechnological processes.
Career Highlights
Pernille's career boasts experience with leading companies in the industry, including Novozymes A/S and Henkel AG & Company, KGaA. Her work in these organizations has been instrumental in advancing biotechnological research and development.
Collaborations
Throughout her career, Pernille has collaborated with esteemed colleagues such as Lars Anderson and Jens Erik Nielsen. These partnerships have fostered innovative ideas and contributed to her successful patent portfolio.
Conclusion
Pernille F. Jensen is a pioneering inventor whose work in enzyme variants represents a critical advancement in biotechnology. Her dedication to research and collaboration continues to influence and drive innovation within the field.